businesspress24.com - Global Clot Management Devices is expected to attain a market size of $1.7billion by 2022
 

Global Clot Management Devices is expected to attain a market size of $1.7billion by 2022

ID: 1529073

Global Clot Management Devices is expected to attain a market size of $1.7billion by 2022, growing at a CAGR of 5.0% during the forecast period.
The factors driving the market for clot management devices are raising incidences of cardiovascular diseases, growing adoption of percutaneous device due to rapid growth in appearance of artificial organs, large patient pool, growing healthcare awareness, investment in healthcare infrastructure and increasing adoption of self-monitoring devices.


(businesspress24) - According to a new report Global Clot Management Devices Market, published by KBV Research, the global Clot Management Devices is expected to attain a market size of $1.7billion by 2022, growing at a CAGR of 5.0% during the forecast period. The factors driving the market for clot management devices are raising incidences of cardiovascular diseases, growing adoption of percutaneous device due to rapid growth in appearance of artificial organs, large patient pool, growing healthcare awareness, investment in healthcare infrastructure and increasing adoption of self-monitoring devices.
The Percutaneous Thrombectomy Devices market dominated the Global Clot Management Market by Product in 2015, and would continue to be a dominant market till 2022; thereby, achieving a market value of $605.7 million by 2022, growing at a CAGR of 3.6% during the forecast period. The Hospitals market dominated the Global Clot Management Market by End User in 2015, and would continue to be a dominant market till 2022; growing at a CAGR of 4.3% during the forecast period. The Diagnostic Centers market is expected to witness a CAGR of 7.5% during (2016-2022).
The North America market dominated the Global Clot Management Market by Region in 2015, and would continue to be a dominant market till 2022; growing at a CAGR of 2.7% during the forecast period. The Asia-Pacific market is expected to witness a CAGR of 7.8% during (2016-2022). The report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key influencing factors of the global Clot Management Devices have been discussed in the report along with the elaborated company profiles of Teleflex Inc., Edwards Lifesciences Corporation, Medtronic Plc, Boston Scientific Corporation, Lemaitre Vascular, Inc., Straub Medical AG, Cook Medical Inc. and Johnson & Johnson.
Full Report: http://kbvresearch.com/global-clot-management-devices-market/




Research Scope
Global Clot Management Devices Market by Product Type





Global Clot Management Devices Market by End User


Global Clot Management Devices Market by Geography

oUS. Clot Management Devices Market
oCanada Clot Management Devices Market
oMexico Clot Management Devices Market
oRest of North America Clot Management Devices Market

oGermany Clot Management Devices Market
oU.K. Clot Management Devices Market
oFrance Clot Management Devices Market
oRussia Clot Management Devices Market
oSpain Clot Management Devices Market
oItaly Clot Management Devices Market
oRest of Europe Clot Management Devices Market

oChina Clot Management Devices Market
oJapan Clot Management Devices Market
oIndia Clot Management Devices Market
oSouth Korea Clot Management Devices Market
oSingapore Clot Management Devices Market
oMalaysia Clot Management Devices Market
oRest of Asia-Pacific Clot Management Devices Market

oBrazil Clot Management Devices Market
oArgentina Clot Management Devices Market
oUAE Clot Management Devices Market
oSaudi Arabia Clot Management Devices Market
oSouth Africa Clot Management Devices Market
oNigeria Clot Management Devices Market
oRest of LAMEA Clot Management Devices Market
Companies Profiled







& Johnson
Related Reports:
North America Clot Management Devices Market
Europe Clot Management Devices Market
Asia Pacific Clot Management Devices Market
LAMEA Clot Management Devices Market

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:

Knowledge Based Value Research is a global brand and consulting firm serving all kinds of business verticals, government and non-governmental organizations, and not-for-profit organizations. Our motto is to extend our services that will have a lasting impact on our clients who trust us with their business goals.



Leseranfragen:



PresseKontakt / Agentur:

244 Fifth Avenue, Suite 1407
New York, N.Y. 10001
United States (U.S)
Tel: +1 (646) 661-6066
Email : info(at)kbvresearch.com



drucken  als PDF  an Freund senden  Aequus stellt Weichen für ein vielversprechendes Jahr 2018
Bereitgestellt von Benutzer: Prity
Datum: 24.12.2018 - 01:38 Uhr
Sprache: Deutsch
News-ID 1529073
Anzahl Zeichen: 5395

Kontakt-Informationen:
Ansprechpartner: KBV Research
Stadt:

New York City


Telefon: 6466616066

Kategorie:

Biochemie


Meldungsart: Produktinformation
Versandart: Veröffentlichung
Freigabedatum: 24.12.2018
Anmerkungen:


Diese Pressemitteilung wurde bisher 576 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Global Clot Management Devices is expected to attain a market size of $1.7billion by 2022
"
steht unter der journalistisch-redaktionellen Verantwortung von

KBV Research (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von KBV Research



 

Who is online

All members: 10 561
Register today: 2
Register yesterday: 2
Members online: 0
Guests online: 69


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.